Could a common supplement stop colon cancer before it starts?
NCT ID NCT07582003
First seen May 19, 2026 · Last updated May 25, 2026 · Updated 1 time
Summary
This early-stage trial tests whether a daily supplement called SAMe can help prevent colorectal polyps (precursors to cancer) in 18 adults who have already had surgery for early-stage colorectal cancer. Participants will take SAMe for up to 12 months while researchers monitor for side effects and check for new polyps during follow-up colonoscopy. The main goal is to find the safest dose for future larger studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADENOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Cedars-Sinai Medical Center
Los Angeles, California, 90048, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.